CN101928727A - Newcastle disease virus Italien strain auxiliary expression plasmid systems, micro genome for detecting system and application thereof - Google Patents

Newcastle disease virus Italien strain auxiliary expression plasmid systems, micro genome for detecting system and application thereof Download PDF

Info

Publication number
CN101928727A
CN101928727A CN201010179881XA CN201010179881A CN101928727A CN 101928727 A CN101928727 A CN 101928727A CN 201010179881X A CN201010179881X A CN 201010179881XA CN 201010179881 A CN201010179881 A CN 201010179881A CN 101928727 A CN101928727 A CN 101928727A
Authority
CN
China
Prior art keywords
leu
ser
sequence
ala
newcastle disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201010179881XA
Other languages
Chinese (zh)
Inventor
边惠洁
尉丁
冯浩
南刚
陈志南
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201010179881XA priority Critical patent/CN101928727A/en
Publication of CN101928727A publication Critical patent/CN101928727A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention relates to different transcript promoter-based newcastle disease virus (NDV) Italien strain auxiliary expression plasmid systems, a micro genome for detecting the systems and application thereof. The system has the advantage that: the obtained auxiliary expression plasmid systems of two sets of NDV Italien strains NP, P and L genes promoted by eukaryotic transcript promoters CMV and T7 respectively can efficiently express virus proteins in eukaryotic cells and eukaryotic cells expressing T7RNA polymerase. Meanwhile, the micro genome, which carries different tag proteins and is used for detecting the auxiliary expression plasmid system for NDV Italien strains, is obtained; and the micro genome can be used for detecting the functions of the constructed three auxiliary protein expression plasmid systems, and meanwhile can be used for research on virus genome functions and recombinant virus preparation.

Description

The micro genome and the application thereof of newcastle disease virus Italien strain auxiliary expression pUC pUC and this system of detection
Technical field
The present invention relates to genetically engineered and biological technical field, particularly make up the micro genome and the application thereof of newcastle disease virus Italien strain auxiliary expression pUC pUC and this system of detection.
Background technology
(Newcastle disease virus NDV) is a kind of strand RNA paramyxovirus that can cause symptoms such as poultry respiratory infection to Avian pneumo-encephalitis virus.The about 15kb of rna gene group total length of NDV, amerism, comprise 6 genes, encode respectively nucleocapsid protein (nucleocapsid protein, NP), phosphorprotein (phosphoprotein, P), stromatin (matrix protein, M), fusion rotein (fusion protein, F), hemagglutinin-neuraminidase (hemagglutinin-neuraminidase, HN) and the RNA polymerase that relies on of RNA (large polymerase, L).Wherein, NP, P and L albumen and virus genomic duplicate and transcribe closely related.Virus nucleocapsid mainly is made of NP albumen, secondly the P and the L albumen that also include some amount, in the process of virus infection host cell, NP, P and L albumen form ribonucleoprotein mixture (RNP) with virus genome RNA, this mixture is exercised the function of the RNA polymerase of RNA dependence, is responsible for transcribing and duplicating of virus genome RNA.
Except that the encoding sequence that contains the 6 kinds of viral proteins of encoding, also comprise being positioned at opening beginning sequence (GS), terminator sequence (GE) and being positioned between the two intermediate sequence (IG) of encoding sequence upstream and downstream in the NDV genome.Wherein, GS and GE sequence are respectively the initial sum termination recognition sites of viral protein genetic transcription.The binding site of regulating and controlling sequence that viral genome is duplicated and viral RNP mixture then is positioned at initial tens of viral genome 5 ' and 3 ' end to the dozens of base, in all NDV strains that GenBank announces, 12 nucleotide sequence high conservatives that above-mentioned base is especially initial.
At present NDV relevant research work be mainly reflected in two aspects: on the one hand, as a kind of important bird virus, NDV can cause the poultry newcastle disease and poultry farming is caused heavy losses, therefore needs the NDV vaccine of research high-efficiency broad spectrum; On the other hand, NDV is a kind of natural oncolytic virus, have that natural selectivity is duplicated and the characteristic of final kill tumor cell in human body tumour cell, and human normal cell and tissue are not had pathogenic, so NDV is considered to a kind of potential antineoplaston preparation.People's expectation can be by carrying out modified recombinant to NDV, and acquisition can be used for the reorganization NDV of clinical therapy of tumor.
Above-mentioned two research directions all relate to the utilization reverse genetic and learn a skill virus is carried out vitro recombination and resurrection.In the NDV resurrection process, except that needs viral genome itself, also three viral protein actings in conjunction of pattern of wants RNP mixture simultaneously just can be finished and genomicly duplicate and transcribe, therefore, the auxiliary expression plasmid of structure NP, P and L gene is necessary in the resurrection process.
Want the eukaryotic expression product of clear and definite NP, P and three kinds of genes of L correctly to express, and can correctly be assembled into the RNP mixture and then exercise normal function, then need to make up a viral micro genome that has label protein and carry out functional verification.The virus micro genome carries the non-coding region and the regulating and controlling sequence at viral genome two ends, the sequence of carrying code tag albumen (as DsRed, luciferase etc.) simultaneously.By the proteic expression of detection label, can verify with viral genome and duplicate and transcribe the proteic function of relevant NP, P and L that therefore, the micro genome of virus also is needed in the vitro recombination virus rescue process simultaneously.Simultaneously, viral micro genome also can be used as a kind of research tool that research viral genome regulating and controlling sequence and non-coding sequence act in the regulation and control viral protein expression.
Summary of the invention
The objective of the invention is for the NP, the P that obtain the Avian pneumo-encephalitis virus virulent strain Italien under two kinds of different transcripting promoters (CMV promotor and the T7 promotor) regulation and control and 6 kinds of eukaryon expression plasmid systems of three genes of L, and the NDV micro genome and the application thereof of carrying different label proteins that are used to detect these three gene expression product functions.
The technical solution adopted in the present invention is:
By the internet database sequence, design can be used for the increasing primer of NDV Italien strain NP, P and L albumen complete encoding sequence.
By the internet database sequence alignment, confirm NDV genome 3 ' and 5 ' conservative region, design simultaneously can be used for NDVItalien strain genome 3 ' and the amplimer of the non-coding region of 5 ' both sides.
By RT-PCR, adopt the corresponding fragment of above-mentioned primer amplification, and check order, confirm corresponding sequence.
Based on pcDNA3.1 (+) eukaryon expression plasmid (CMV promotor), NP, P and L gene cloned respectively to enter corresponding site and carry out the eucaryon transient expression, plasmid is called after pcDNA-NP, pcDNA-P and pcDNA-L respectively.Wherein NP gene expression plasmid pcDNA-NP comprises the sequence of SEQ No 1, its expression product comprises the aminoacid sequence of SEQ No 4, P gene expression plasmid pcDNA-P comprises the sequence of SEQ No 2, its expression product comprises the aminoacid sequence of SEQ No 5, L gene expression plasmid pcDNA-L comprises the sequence of SEQ No 3, its expression product comprises the aminoacid sequence of SEQ No 6, and above-mentioned plasmid is expressed newcastle disease virus Italien strain NP albumen, P albumen and L albumen respectively in eukaryotic cell.
Go up amplification internal ribosome entry site (IRES) sequence by pIRES2-EGFP, and add the t7 rna polymerase promoter sequence at its upstream, the amplification fragment of gained and NP, P and L gene fragment are connected in the pMD-19T carrier successively, and transient expression in can the eukaryotic cell of stably express T7 RNA polymerase, formation is distinguished called after T7-NP, T7-P and T7-L based on NP, P and the L expression of gene plasmid of T7 promotor.Wherein NP gene expression plasmid T7-NP comprises the sequence of SEQ No 1, its expression product comprises the aminoacid sequence of SEQ No 4, P gene expression plasmid T7-P comprises the sequence of SEQ No 2, its expression product comprises the aminoacid sequence of SEQ No 5, L gene expression plasmid T7-L comprises the sequence of SEQ No 3, its expression product comprises the aminoacid sequence of SEQ No 6, and above-mentioned plasmid is expressed newcastle disease virus Italien strain NP albumen, P albumen and L albumen respectively in the eukaryotic cell that contains the T7 RNA polymerase.
The method that adopts overlap PCR successively with NDV Italien pnca gene group 3 ' and 5 ' end non-coding sequence and label protein complete encoding sequence oppositely be inserted between sub and hepatitis D virus autocatalysis ribozyme (HDV ribozyme) sequence of phage t7 rna polymerase promoter and connect into cloned plasmids, wherein viral genome 3 ' non-coding region cDNA sequence comprises the sequence of SEQ No 7, viral genome 5 ' non-coding region cDNA sequence comprises the sequence of SEQ No 8, makes up to obtain NDV Italien micro genome.Wherein label protein adopts red fluorescent protein DsRed and Photinus pyralis LUC respectively, corresponding plasmid called after MG-R and MG-L.
Respectively based on NP, P and the L expression plasmid cotransfection of CMV promotor and T7 promotor, the function of NP, P and L expression plasmid and micro genome is confirmed in the proteic expression of detection label with resulting two kinds of micro genome and two covers.
At last, resulting two plasmids that comprise NDV Italien plasmid full-length gene group cDNA sequence that overlap NP, P and L expression plasmid system and structure are carried out cotransfection, successfully in the external resurrection of carrying out recombinant virus.
Described newcastle disease virus Italien strain auxiliary expression pUC pUC is as external preparation recombinant virus or as the application for preparing viral micro genome.
The micro genome of described detection newcastle disease virus Italien strain auxiliary expression pUC pUC is as external preparation recombinant virus or as the application in newcastle disease virus Italien strain NP albumen, P albumen and proteic preparation of L or the Function Identification.
The invention has the beneficial effects as follows: adopted two cover NDV Italien strain NP, the P of eukaryotic transcription promotor CMV promotor and T7 promotor startup and the auxiliary expression pUC pUC of L gene respectively, can and can in the eukaryotic cell of expressing the T7 RNA polymerase, efficiently express viral protein at eukaryotic cell.Two kinds of micro genome of carrying the detection newcastle disease virus Italien strain auxiliary expression pUC pUC of different reporter genes have been obtained simultaneously, can be used for detecting the function of three kinds of constructed accessory protein expression plasmid systems, also can be used for the research of viral genome function and recombinant virus simultaneously.
Description of drawings
Fig. 1 is the pcDNA-NP plasmid map.
Fig. 2 is the pcDNA-P plasmid map.
Fig. 3 is the pcDNA-L plasmid map.
Fig. 4 is pcDNA-NP transfection BSR-T7/5 cell transient expression NP protein immunization fluoroscopic examination result (400 *), and one is anti-: the anti-NDV polyclonal antibody of rabbit; Two is anti-: goat anti-rabbit igg-Cy3 antibody.
Fig. 5 is pcDNA-P transfection BSR-T7/5 cell transient expression P protein immunization fluoroscopic examination result (400 *), and one is anti-: the anti-NDV polyclonal antibody of rabbit; Two is anti-: goat anti-rabbit igg-Cy3 antibody.
Fig. 6 is the T7-NP plasmid map.
Fig. 7 is the T7-P plasmid map.
Fig. 8 is the T7-L plasmid map.
Fig. 9 is T7-NP transfection BSR-T7/5 cell transient expression NP protein immunization fluoroscopic examination result (200 *).One is anti-: the anti-NDV polyclonal antibody of rabbit; Two is anti-: goat anti-rabbit igg-FITC antibody.
Figure 10 is T7-P transfection BSR-T7/5 cell transient expression P protein immunization fluoroscopic examination result (200 *), and one is anti-: the anti-NDV polyclonal antibody of rabbit; Two is anti-: goat anti-rabbit igg-Cy3 antibody.
Figure 11 is the MG-R plasmid map.
Figure 12 is the expression of results that cell pyrolysis liquid detects DsRed behind MG-R and pcDNA-NP, pcDNA-P and the pcDNA-L cotransfection BSR-T7/5 cell by western blot.
A: transfection micro genome plasmid MG-R;
B: cotransfection helper plasmid pcDNA-NP, pcDNA-P and pcDNA-L;
C: cotransfection helper plasmid pcDNA-NP, pcDNA-P and pcDNA-L and micro genome plasmid MG-R.
Figure 13 is the MG-L plasmid map.
Figure 14 is the expression of results that cell pyrolysis liquid detects Photinus pyralis LUC behind MG-L and T7-NP, T7-P and the T7-L cotransfection BSR-T7/5 cell by the Photinus pyralis LUC reporting system.
Embodiment
1. experiment material
1.1 virus and clone
Virulent strain NDV Italien is by Volker Schirrmacher (Division of Cellular Immunology, German Cancer Research Center, Germany) present;
The BSR-T7/5 cell is by Karl-Klaus Conzelmann (Ludwig-Maximilians-UnivercityMunich, Germany) present;
The SMMC-7721 cell strain is available from Shanghai Chinese Academy of Sciences cell bank.
1.2 bacterial classification and plasmid
PIRES2-EGFP and pDsRed1-N1 plasmid are available from Clontech company;
PcDNA-3.1 (+) plasmid is available from Invitrogen company;
The pGL3-Basic plasmid is available from Promega company;
PMD-19T simple vector T carrier is available from TaKaRa company;
E.coli DH5 α provides for oneself in the laboratory.
1.3 main agents
DMEM high glucose medium (Hyclone company);
Foetal calf serum (Hangzhou folium ilicis chinensis biotech company);
Viral RNA/DNA fast purifying test kit (TaKaRa company);
Figure GSA00000131317800051
RT reverse transcription test kit (TaKaRa company);
Restriction enzyme,
Figure GSA00000131317800052
HS DNA enzyme, T4DNA ligase enzyme (TaKaRa company);
Plasmid extraction test kit, dna gel purification kit (OMEGA company);
Lipofectamine 2000 (Invitrogen company);
4% Paraformaldehyde 96 stationary liquid;
0.5%Triton solution;
The anti-NDV serum of rabbit is by Volker Schirrmacher (Division of Cellular Immunology, GermanCancer Research Center, Germany) present;
Goat anti-rabbit igg-Cy3 monoclonal antibody (Sigma company);
Pathogen-free domestic chicken kind egg is available from the logical laboratory animal technology company limited of Beijing Cimmeria dimension.
2. method
2.1 design of primers
Based on the GenBank database, choose NP, P and L albumen coded sequence two ends design primer, add Kozak sequence and two sections corresponding restriction enzyme sites simultaneously, primer sequence such as following table (underscore is represented restriction enzyme site):
The primer title Primer sequence (5 ' to 3 ' direction)
NP-F1 tataagcttgccaccatgtcttccgtattcgac
NP-F2 tatccatgggccaccatgtcttccgtattcgac
NP-R taattctagagtcctgtggaggcagactgggt
P-F1 ggaccttaagcagcggattagggtgaag
P-F2 attccatgggccaccatggccacctttacagat
P-R ggcgtctagatgtgacactgaaaagga
L-F1 taatgcggccgccacggctaaacaactcac
L-F2 taaccatgggccaccatggcaagctccggtcc
L-R gcattctagatgaatccgaatacgagtctt
IRES-F agtaatacgactcactatagggtctcgagctcaagcttcg
IRES-R aattctagaaatccatggttacttgtacagctcgtc
In the above-mentioned primer, NP-F1 and NP-R, P-F1 and P-R, L-F1 and L-R increase respectively NDV Italien strain NP, P and L gene coded sequence, called after NP1, P1 and L1 are inserted into respectively in the corresponding restriction enzyme site of pcDNA3.1 (+) respectively.
In the above-mentioned primer, NP-F2 and NP-R, P-F2 and P-R, L-F2 and L-R increase respectively NDV Italien strain NP, P and L gene coded sequence, called after NP2 respectively, P2 and L2 are inserted into respectively in the expression plasmid that only carries the T7 promotor.
In the above-mentioned primer, IRES-F and IRES-R are used for from the pIERS2-EGFP plasmid amplification IRES complete sequence, products therefrom called after IRES.
By the internet database sequence alignment, confirm NDV genome 3 ' and 5 ' conservative region and design primer, synthetic NDV Italien pnca gene group 3 ' and the amplimer of the conservative region of 5 ' both sides that can be used for.Primer sequence such as following table:
The primer title Primer sequence (5 ' to 3 ' direction)
Tailer-F gccaccacctgttcctgtagtaaaggcaatcacatatt
Tailer-R tatctagagtaatacgactcactatagggaccaaacaaagatttggt
Leader-F ttcggaccgcgaggaggtggagatgccatgccgacccaccaaacagagattctgtga
Leader-R gaggagcgcaccatggtggcgtcagcagaaggctctct
DsRed-F gccaccatggtgcgctcctc
DsRed-R ctacaggaacaggtggtggc
PairA-F agtaatacgactcactat
PairA-R aggcaatcacatattaa
Luci-F agagccttctgctgacaaagccaccatggaagacgcc
Luci-R taatatgtgattgcctttacacggcgatctttcc
PairB-F gtcagcagaaggctctct
PairB-R ttataagctaatcggccg
That Tailer-F and Tailer-R, Leader-F and Leader-R are respectively applied for amplification NDV Italien is genomic 3 ' and 5 ' non-coding region, and add T7 promoter sequence and section H DV ribozyme sequence respectively at two ends, products therefrom is called after TS and LS respectively.DsRed-F and DsRed-R are used for from the encoding sequence of plasmid pDsRed1-N1 amplification DsRed, products therefrom called after DS.
PairA-F and PairA-R, PairB-F and PairB-R are respectively applied for by 3 of amplification NDV Italien pnca gene group among the micro genome plasmid MG-R (seeing 2.7) ' and the T7 promotor and the HDV ribozyme sequence of 5 ' non-coding region and both sides thereof, and products therefrom is called after PairA and PairB respectively.Luci-F and Luci-R are used for from the encoding sequence of plasmid pGL3-Basic amplification Photinus pyralis LUC, products therefrom called after Luci.
2.2 virus culture and purifying
NDV Italien strain is inoculated in the allantoic cavity of pathogen-free domestic chicken embryo of 9 ages in days.Select chicken embryo dead after 48 hours, collect allantoic fluid.By the low temperature ultracentrifugation to obtain spissated viral suspension.
2.3 the acquisition of encoding hiv protease sequence and genome two ends non-coding sequence
Extracting the geneome RNA of gained virus in 2.2, by segmentation RT-PCR, adopt primer designed in 2.1 to obtain the cDNA subfragment, is respectively the encoding sequence of NDV Italien strain NP, P and L and genome 3 ' and 5 ' end non-coding sequence.The fragment of gained all reclaims test kit by gel and carries out purifying, is connected in the T carrier and checks order, and confirms the segmental exactness of gained.
2.4 the acquisition of IRES sequence, DsRed encoding sequence and Photinus pyralis LUC encoding sequence
Utilize institute's synthetic primer in 2.1, amplification IRES fragment from plasmid pIRES2-EGFP, amplification DsRed complete encoding sequence from plasmid pDsRed1-N1, amplification Photinus pyralis LUC complete encoding sequence from plasmid pGL3-Basic.The PCR product of gained is connected in the T carrier and checks order, and confirms the segmental exactness of gained.
2.5 structure and checking based on virus N P, P and the L gene expression plasmid of CMV transcripting promoter
Gained fragment NP1, P1 in 2.3 and L1 (name sees 2.1) are cut by corresponding enzyme respectively, insert in pcDNA3.1 (+) multiple clone site, the plasmid that is constituted is through order-checking, after confirming that connection and fragment sequence are correct, difference called after pcDNA-NP (Fig. 1), pcDNA-P (Fig. 2) and pcDNA-L (Fig. 3).
With plasmid pcDNA-NP and the pcDNA-P that obtains, by liposome Lipofectamine 2000 transfection BSR-T7/5 cells, transfection detected NP and the proteic expression of P by indirect immunofluorescence method after 36 hours, the result all detects the expression of corresponding viral protein product as shown in Figure 4 and Figure 5.
2.6 structure and checking based on virus N P, P and the L gene expression plasmid of T7 promotor
Resulting IRES sequence in 2.4 directly is connected into the T carrier, adopt enzyme butt formula to be cloned into carrier respectively resulting fragment NP2, P2 in 2.3 and L2 (name sees 2.1) again, the fragment of gained is at last through order-checking, after determining that connection and insertion fragment are correct, difference called after T7-NP (Fig. 6), T7-P (Fig. 7) and T7-L (Fig. 8).
T7-NP and T7-P are utilized liposome Lipofectamine 2000 transfection BSR-T7/5 cells respectively, after the transfection 36 hours, detect NP and the proteic expression of P by indirect immunofluorescence method, result such as Fig. 9 and shown in Figure 10 all detect the expression of viral protein product.
2.7 carry the structure of the viral micro genome of DsRed encoding sequence
With resulting fragment TS, LS in 2.3 and 2.4 and DS (name sees 2.1) method by overlap PCR, utilize the overlapping complementary region between the primer to connect, again resulting junction fragment is connected in the T carrier, plasmid with gained checks order subsequently, after confirming that connection and fragment sequence are correct, with the plasmid called after MG-R (Figure 11) of gained.
2.8 carry the DsRed encoding sequence viral micro genome and based on virus N P, the P of CMV promotor and the detection of L gene eucaryon expression plasmid function
With pcDNA-NP, pcDNA-P constructed among the MG-R and 2.5 constructed in 2.7 and pcDNA-L plasmid by liposome Lipofectamine 2000 cotransfection BSR-T7/5 cells, lysing cell after 24 hours, western blot method detects DsRed and expresses, the result shows that DsRed successfully expresses as shown in figure 12.Verified also that simultaneously the constructed pcDNA-NP of the present invention, pcDNA-P and pcDNA-L plasmid can express and have the function of assembling the RNP mixture in eukaryotic cell.
2.9 carry the structure of the viral micro genome of Photinus pyralis LUC
With resulting fragment PairA, PairB in 2.3 and 2.4 and Luci (name sees 2.1) method by overlap PCR, utilize the overlapping complementary region between the primer to connect, resulting junction fragment is connected in the T carrier, plasmid with gained checks order subsequently, after confirming that connection and fragment sequence are correct, with the plasmid called after MG-L (Figure 13) of gained.
2.10 carry the viral micro genome of Photinus pyralis LUC and based on virus N P, the P of T7 promotor and the detection of L gene expression plasmid function
2.9 resulting MG-L are passed through liposome Lipofectamine 2000, with 2.6 in resulting plasmid T7-NP, T7-P and the common transfection BSR-T7/5 of T7-L cell, after the transfection 24 hours, lysing cell, cell pyrolysis liquid is added the Photinus pyralis LUC reaction substrate, detect luciferase expression intensity, gained data credit are by statistics analysed, the result shows Photinus pyralis LUC successful expression among the MG-L as shown in figure 14.Verified also that simultaneously the constructed T7-NP of the present invention, T7-P and T7-L plasmid can express and have the function that is assembled into the RNP mixture in eukaryotic cell.
2.11 T7-NP, T7-P and the T7-L plasmid application in preparation NDV Italien recombinant virus
The plasmid co-transfection BSR-T7/5 cell that comprises NDVItalien full-length gene group cDNA sequence that the T7-NP, the T7-P that make up in 2.6 and T7-L expression plasmid and the inventor were made up in the past, after the transfection 7 days, observe the cytopathy that virus causes, and do not observe this phenomenon at control group.By multigelation experimental group cell, the collecting cell lysate, lysate is infected the BSR-T7/5 cell once more with the amplification recombinant virus, detect specific fragment of recombinant virus genomes and order-checking by the RT-PCR method, sequencing result shows inserted one section distinctive exogenous genetic fragment between viral genome HN and F gene, confirmed that resulting virus is the recombinant virus of external structure, shown external resurrection recombinant virus success.This experiment shows that simultaneously T7-NP, T7-P and T7-L expression plasmid system can prepare recombinant virus with comprising the acting in conjunction of viral genome plasmid external.
Sequence table
<110〉Chen Zhinan
 
<120〉micro genome and the application thereof of newcastle disease virus Italien strain auxiliary expression pUC pUC and this system of detection
 
<160>8
 
<210>1
<211>1747
<212>DNA
<213〉newcastle disease virus Italien strain (Newcastle disease virus Italien strain)
 
<220>
<221>CDS
<222>(67)..(1536)
<223〉newcastle disease virus Italien strain NP gene
 
<400>1
acgggtagaa?ggtgtgaatc?tcgagtgcga?ggccgaagct?caaactcgag 50
agagccttct?gctgacatgt?cttccgtatt?cgacgaatat?gagcagctcc 100
tcgcggctca?gactcgccct?aatggagctc?acggaggagg?agaaaagggg 150
agcactttaa?aagttgaggt?cccggtattc?actcttaaca?gtgatgatcc 200
agaagacaga?tggaattttg?cggtattctg?tcttcggatt?gctgttagcg 250
aggatgccaa?caaaccactc?aggcaaggtg?ctctcatatc?tctcttatgc 300
tcccactctc?aagtgatgag?gaaccatgtt?gcccttgcag?ggaaacagaa 350
tgaggccaca?ctggctgttc?ttgagatcga?tggttttacc?aacagtgtgc 400
cccagttcaa?caacaggagt?ggagtgtctg?aagagagagc?acagagattc 450
ttgatgatag?caggatctct?ccctcgagca?tgcagcaatg?gtactccgtt 500
cgtcacagct?ggggttgaag?atgatgcacc?agaagatatc?actgatactc 550
tggaaagaat?cctatctatc?caggctcaag?tatgggtcac?ggtagcaaag 600
gccatgactg?catatgagac?agcagatgag?tcggaaacaa?gaagaatcaa 650
taaatatatg?cagcaaggca?gagtccagaa?gaagtacatc?ctccaccccg 700
tatgcaggag?tgcaattcaa?ctcacgatca?gacattccct?ggcagtccgc 750
attttcttag?ttagcgagct?taagagaggc?cgcaacacgg?caggtgggag 800
ctccacctat?tacaacttgg?taggggatgt?agactcatac?atcaggaaca 850
ccgggcttac?tgcattcttc?ctgacactca?aatatgggat?taataccaag 900
acatcagccc?ttgcactcag?cagcctcaca?ggcgatatcc?aaaaaatgaa 950
gcagctcatg?cgtttatatc?ggataaaagg?agaaaatgcg?ccatacatga 1000
cattgctagg?tgacagtgac?cagatgagct?ttgcaccagc?tgagtatgca 1050
caactttact?ctttcgccat?gggcatggca?tcagtcctag?ataaaggaac 1100
tggcaaatac?caatttgcca?gagactttat?gagcacatca?ttttggagac 1150
ttggagtaga?gtatgctcag?gctcagggaa?gtagcatcaa?tgaggatatg 1200
gctgccgagc?taaaactaac?cccagcagca?aggaggggcc?tggcagctgc 1250
tgcccaacga?gtgtctgagg?agaccggcag?catggatatt?cctactcaac 1300
aagccggggt?cctcaccggg?ctcagcgacg?gaggccctcg?agccccacaa 1350
ggtggatcaa?acaggccgca?agggcaaccg?gatgccggag?atggggagac 1400
ccaattcctg?gatttgatga?gagcggtggc?aaatagcatg?cgagaagcgc 1450
caaactccgc?acagagcacc?acccaaccgg?agcctccttc?aactcctggg 1500
ccgtcccaag?gcaatgacac?cgactgggggtactgaccga?caatacccag 1550
cctgcctcca?caggaccacc?ccaacccctc?tgcccgcacc?ccaccccctg 1600
atccgcagcc?ccgcatggcc?aaacccacaa?aagaaccccc?ccatctcccc 1650
tcctccctcc?agctgcacga?ccccacccgc?ccaaggcaac?ataggcacag 1700
cccgacccac?caacagtcta?tacagagcca?aagatattag?aaaaaaa 1747
 
<210>2
<211>1451
<212>DNA
<213〉newcastle disease virus Italien strain (Newcastle disease virus Italien strain)
 
<220>
<221>CDS
<222>(84)..(1271)
<223〉newcastle disease virus Italien strain P gene
 
<400>2
acgggtagaa?gagaggcatt?cagagaccaa?gacgagtcac?tagggtctct?50
gttctccctt?ctacccagcg?gattagggtg?aagatggcca?cctttacaga?100
tgcggagatc?gacgatatat?ttgagaccag?cggaactgtc?attgacagca?150
taattacggc?ccagggtaaa?tcagcagaga?ctgtcgggag?gagcgcaatc?200
ccacaaggca?agaccaaagc?gttaagcgca?gcatgggaga?agcatgggag?250
catccaacca?ccggccagcc?aagataccct?tgaccaacag?gatagatcag?300
acaagcagcc?atccacacct?gaacaggcga?ctccacataa?cagcccgcca?350
gccacatcca?ccgaccagcc?ccccacccag?gccgcaggcg?aggccggcga?400
cacacagctc?aagaccggag?caagcaactc?acttttgtcg?atgctcgaca?450
agcttagcaa?taaatcgtct?aatgctaaaa?agggcccatg?ggcgagtccc?500
caggaagggc?atcatcaacc?tccggcccaa?cagcagggga?gtcaaccgag?550
ccgcgggaac?aatcaggaaa?gaccgcagaa?ccaggccaag?gccgcccctg?600
gagaccgggg?cacagacgcg?aacacagcat?atcctggaca?atggaaggag?650
tcacaactat?cagctggtgt?aacccctcat?gcgctccggt?cagggcagag?700
ccaagacaat?actcctgcac?ctgtggatca?tgtccagcta?cctgtcgact?750
ttgtgcaggc?gatgatgtct?atgatggagg?cgttatcaca?gagggtaagt?800
aaagttgact?atcagctaga?cctagtttta?aaacagacat?cctccatccc?850
catgatgcgg?tctgaaatcc?aacagctaaa?aacatccgtt?gcggtcatgg?900
aagccaattt?gggcatgatg?aaaattctgg?accctggttg?tgctaacgtt?950
tcatctctaa?gtgatttacg?ggcagtcgcc?cgatcccacc?cagttttaat?1000
ttcaggtccc?ggagatccat?ctccttatgt?gacgcaaggg?ggcgaaatga?1050
cactcaataa?actttcacaa?ccagtgctac?atccgtctga?gttaattaaa?1100
cctgccacgg?caagcgggcc?tgacatggga?gtggagaagg?acactgtccg?1150
tgcattgatc?acctcacgtc?cgatgcatcc?gagctcctca?gctaagctcc?1200
tgagtaagct?ggatgcagcc?gggtcgattg?aagagatcag?gaaaatcaag?1250
cgccttgcgc?tgaatggctg?atcactatca?caacctacaa?caggttcccg?1300
ccttttcagt?gtcacaagga?ctctgccctg?agctttcccc?cataaaccca?1350
agcttcaaca?ctttaggtga?taaccccttc?tcacctcccc?taccccattg?1400
agtgatcgcg?caactgcaat?taatctagca?gcattaaaga?ttaagaaaaa?1450
a 1451
 
<210>3
<211>6703
<212>DNA
<213〉newcastle disease virus Italien strain (Newcastle disease virus Italien strain)
 
<220>
<221>CDS
<222>(12)..(6626)
<223〉newcastle disease virus Italien strain L gene
 
<400>3
acgggtagga?catggcaagc?tccggtcccg?aaagggcaga?gcatcagatc?50
atcctaccag?agtcacacct?atcctcacca?ttggtcaagc?acaaactgct?100
ctattactgg?aaattgactg?ggctaccgct?tcctgacgaa?tgtgacttcg?150
accacctcat?tatcagccga?caatggaaga?aaatacttga?atcggccact?200
cctgacactg?agaggatgat?aaaactcggg?cgggcagtac?accagactct?250
caaccacagt?tccaggataa?ccggagtact?ccatcccagg?tgtttagaag 300
aactggctag?tattgaggtc?cctgattcaa?ccaacaaatt?tcggaagatc 350
gagaagaaga?tccaaattca?caacacaagg?tatggagaac?tgtttacaag 400
gctgtgcacg?catgtagaaa?agaaattgtt?ggggtcgtcc?tggtctagca 450
atgtcccacg?atcagaggaa?ttcaacagca?tccgtacaga?tccggcattc 500
tggtttcact?caaaatggtc?cagagctaag?tttgcatggc?tccatataaa 550
acaggtccaa?aggcacctga?ttgtagcagc?aagaacaagg?tccgcagtca 600
acaaattagt?gacgctgacc?cataagatag?gccaagtctt?tgttactcct 650
gagcttgtcg?ttgtgacaca?tacagatgag?aacaagttca?catgcctcac 700
ccaggaactt?gtgttgatgt?atgcggatat?gatggagggc?agagatatgg 750
tcaacataat?atcatccacg?gcagcacatc?tcaagagctt?atcagagaaa 800
attgatgaca?ttctgcggtt?agtagatgct?ctggcaaaag?atttgggcaa 850
tcaagtctac?gatgttgtag?cactaatgga?gggattcgca?tacggcgccg 900
ttcagctgct?ggagccgtca?ggtacatttg?caggggattt?cttcgcattc 950
aacctgcagg?agctcaaaga?tactctaatc?gagctccttc?ccaaggatat 1000
agcagagtcc?gtgactcacg?caatcgccac?cgtattctct?ggcttagaac 1050
agaatcaagc?agctgagatg?ttgtgcctgc?tgcgtctgtg?gggtcaccca 1100
ctgcttgagt?cccgtgttgc?agcaaaagca?gtcaggagcc?agatgtgcgc 1150
accgaagatg?gtagacttcg?atatgatcct?ccaggtatta?tctttcttta 1200
agggaacaat?catcaatgga?tacagaaaga?agaatgcagg?tgtgtggcca 1250
cgtgtcaaga?tgggtacgat?atacgggaag?gtcattgggc?agctacacgc 1300
agattcagca?gagatttcac?atgatgtcat?gttgagagag?tacaagagtt 1350
tatctgcact?tgaattcgag?ccatgtatag?aatatgaccc?cgtcaccaat 1400
ctaagcatgt?ttctaaaaga?caaggcaatc?gcacacccaa?aagataactg 1450
gctcgcctcg?tttaggcgaa?accttctctc?tgaggaccag?aagaaacatg 1500
ttaaagaggc?aacctcgact?aaccgcctct?tgatagagtt?cttagagtca 1550
aatgattttg?atccatataa?ggagatggaa?tatctgacga?cccttgagta 1600
cctaagagat?gacaacgtgg?cagtatcata?ctcactcaaa?gaaaaggagg 1650
tgaaagttaa?tgggcggatt?ttcgctaagt?taacaaagaa?actaaggaac 1700
tgtcaggtaa?tggcagaagg?gattctagcc?gaccagattg?cacctttttt 1750
ccaggggaat?ggggtcattc?aggatagcat?atctttgact?aagagtatgc 1800
tagcgatgag?tcaactgtcc?ttcaacagca?ataagaaacg?tatcaccgac 1850
tgcaaggaaa?gagtatcctc?aacccgcaat?cacgatccga?agagcaagaa 1900
tcgtcggaga?gttgccacct?ttattacaac?tgacctgcaa?aagtattgtc 1950
ttaactggag?atatcagaca?gtcaagctgt?ttgctcatgc?catcaatcag 2000
ctgatgggcc?tacctcactt?ctttgagtgg?attcatctta?gactcatgga 2050
tactacgatg?tttgtaggag?acccttacaa?tcctccaagt?gacccgaccg 2100
actgtgatct?atcaagagtc?ccaaatgatg?acatatatat?tgtcagtgct 2150
agagggggca?ttgagggatt?gtgccagaag?ctatggacaa?tgatctcaat 2200
tgctgcaatc?caacttgctg?cagcaagatc?acattgtcgt?gttgcctgta 2250
tggtacaagg?tgacaatcaa?gtaatagctg?taacgagaga?ggtaagatca 2300
gatgattccc?cggagatggt?gttaacacaa?ttgcaccaag?ccagtgataa 2350
tttcttcaag?gaattgattc?atgtcaatca?tttgattggc?cataatttaa 2400
aagatcgaga?aaccatcagg?tcagacacat?tcttcatata?cagcaaacga 2450
atattcaaag?atggagcaat?tctcagtcag?gtcctcaaga?actcatctaa 2500
attagtgcta?atatcaggcg?accttagtga?gaacactgta?atgtcttgtg 2550
ccaacattgc?atccactata?gcacggctgt?gcgagaacgg?gcttcctaag 2600
gatttctgtt?actatttaaa?ctacctaatg?agttgtgtgc?agacatactt 2650
tgattctgag?ttttccatca?ctaacaactc?gcaacccgat?tccaaccaat 2700
cgtggattga?ggacatctct?ttcgtgcatt?catatgtcct?gacccctgcc 2750
cagctggggg?gactgagtaa?ccttcaatac?tcaaggctct?acacaaggaa 2800
cattggtgac?ccggggacta?ctgcttttgc?agaggtcaag?cggttagagg 2850
cagtggggtt?actgagtcct?agcattatga?ctaatatctt?aactaggcca 2900
cctggaaatg?gagattgggc?cagtctgtgc?aacgatccat?attcctttaa 2950
ttttgagact?gtcgcgagcc?caaatattgt?acttaagaaa?catacacaga 3000
aagtcctatt?tgaaacttgc?tcaaatcccc?tattatccgg?agtacataca 3050
gaggataatg?aagcagaaga?gaaggcattg?gctgaattct?tgctcaatca 3100
agaagtaatt?cacccacgcg?tcgcgcatgc?tatcatggaa?gcaagctctg 3150
taggtaggag?aaagcaaatt?caggggcttg?ttgacacaac?aaacaccgtg 3200
attaagattg?cgctgactag?gaggccactc?ggcatcaaga?ggctgatgcg 3250
gatagtcaat?tactcgagca?tgcatgcaat?gctatttaga?gatgatgttt 3300
tctcgtccaa?cagatccaac?caccccttag?tctcttctaa?tatgtgttcg 3350
ctgacgctgg?cagattatgc?gcggaacaga?agctggtcac?ctttaacagg 3400
aggtagaaaa?atactgggtg?tatctaatcc?tgataccata?gaacttgtag 3450
agggtgagat?cctcagtgtc?agcggagggt?gcacaaaatg?tgacagcgga 3500
gatgaacagt?ttacctggtt?ccatcttcca?agcaatatag?agctgaccga 3550
tgacaccagc?aagaatcctc?cgatgagagt?gccatatctc?ggatcaaaga 3600
ctcaagagag?gagggccgcc?tcgcttgcga?aaatagccca?tatgtcacca 3650
catgtgaagg?cggcactaag?ggcatcatct?gtgttaatct?gggcttatgg 3700
ggacaacgaa?gtaaattgga?ctgctgctct?taagattgca?aagtctcggt 3750
gcaacataag?ttcagagtat?cttcgactat?tgtcacccct?gccaacagcc 3800
gggaatctcc?aacatagatt?ggatgatggc?ataacccaga?tgacgtttac 3850
ccctgcatct?ctctacagag?tatcacctta?cattcacata?tccaatgatt 3900
ctcaaaggct?atttactgaa?gaaggagtca?aggaggggaa?tgtggtttat 3950
cagcaaatta?tgctcttggg?tttatctcta?attgagtcac?tcttcccaat 4000
gacaacaacc?aagacatatg?atgaaatcac?attgcacctc?cacagtaaat 4050
ttagctgctg?tatcagggaa?gcacctgttg?cagttccttt?cgagctactc 4100
gggttggcac?cagaactaag?ggcggttact?tcgaataagt?ttatgtacga 4150
tcctagccct?gtatcggagg?gagactttgc?gagacttgat?ctagccatct 4200
ttaagagtta?tgagctgaat?ttagagtcat?atcccacaat?agagctaatg 4250
aacattcttt?caatatctag?tgggaagttg?attggccagt?ctgtggtttc 4300
ctatgatgaa?gatacctcta?taaagaatga?cgctataata?gtgtatgaca 4350
acacacgaaa?ttggatcagc?gaagctcaga?attcagatgt?ggtccgccta 4400
ttcgagtatg?cggcacttga?agtgctcctc?gactgctctt?atcaactcta 4450
ctatctgagg?gtaagaggcc?taaacaatat?cgtcctatat?atgagtgatt 4500
tatacaagaa?tatgccagga?attttactct?cgaatattgc?ggctacgata 4550
tctcacccca?tcatccattc?aaggttgaat?gcagtaggtc?tagtcaacca 4600
tgacgggtca?caccaacttg?cagacacaga?tttcattgaa?atgtctgcaa 4650
aactgctagt?ctcttgcact?cgacgcgtgg?tctcaggttt?atatgcaggg 4700
aataggtatg?acctgctgtt?cccatctgtc?ttagatgata?acctgagtga 4750
gaagatgctt?cagttgatat?ctcggttatg?ctgtctgtac?acggtgctct 4800
ttgctacaac?aagagaaatc?ccgaaaataa?gaggcttatc?tgcagaagag 4850
aaatgctcgg?tacttactga?atacttactg?tcagatgctg?tgaaaccatt 4900
acttaggtcc?gagcaagtga?gctctatcat?gtctcccaac?ataattacat 4950
tcccagccaa?tctatattac?atgtctagga?agagccttaa?tttggtcagg 5000
gaaagagagg?atagggatac?tatcttggca?ttgttgttcc?ctcaagaacc 5050
attgctcgag?tttccttcag?tacaagatat?tggtgctcga?gtgaaagatc 5100
catttacccg?acaacctgcg?gcgttcttac?aagagttaga?tttgagtgcc 5150
ccagcaaggt?atgacgcgtt?tacacttagt?caggttcact?ctgaacacac 5200
attgccgaac?ccagaggaag?actatttagt?acgatacttg?ttcagaggaa 5250
tagggactgc?gtcctcctct?tggtataagg?catctcatct?tctttctgta 5300
cccgaggtca?gatgtgcaag?gcatggaaac?tccttatact?tggcagaagg 5350
aagtggagcc?attatgagtc?ttcttgaatt?gcatgtaccg?catgaaacta 5400
tctattacaa?tacgcttttt?tctaatgaga?tgaacccccc?acagcgacat 5450
ttcggaccga?ccccaacaca?gtttctaaat?tcggtcgttt?ataggaatct 5500
acaggcggaa?gtaccatgca?aggatggatt?tgttcaggag?ttccacccat 5550
tatggagaga?gaatacagaa?gagagtgacc?tgacctcaga?taaagcggtg 5600
ggatatatca?catctgcagt?gccttacagg?tctgtatcat?tattgcactg 5650
tgacattgaa?attcctccag?gatccaatca?aagcttacta?gatcaactgg 5700
ctaccaattt?atccctgatt?gccatgcact?ctgtaagaga?gggcggggtc 5750
gttatcatca?aagtactgta?tgcaatgggg?tactacttcc?atctactcat 5800
gaatttgttc?gctccatgtt?ccacgaaagg?atatattctc?tctaatggct 5850
atgcatgtag?aggggatatg?gagtgttact?tgatatttgt?catgggctat 5900
ctaggcgggc?ctacatttgt?gcacgaggtg?gtgaggatgg?caaaaactct 5950
agtacggcgg?cacggtacac?ttctgtctaa?atcagatgaa?attacactga 6000
ctaggttatt?tacctcacag?cagcatcgtg?taacagacat?cctatccagc 6050
cctttaccga?gactaatgaa?gttcttgaga?gagaatattg?atgctgcgct 6100
gattgaagcc?gggggacagc?ctgtccgtcc?attctgtgca?gagagtttag 6150
tgagcacact?aaaagatatg?actcagatga?cccagatcat?cgccagccac 6200
attgacacgg?tcattcgatc?tgtgatctac?atggaagctg?agggtgatct 6250
tgccgacaca?gtgttcttat?ttacccctta?caatctctct?acagacggta 6300
aaaagaggac?atcacttaaa?cagtgcacaa?gacagatcct?agaggtcaca 6350
atactgggtc?tcagggccaa?agatctcaat?aaagtaggtg?atgtaatcgg 6400
cctagtgctc?agaggtatga?tttctctgga?ggacctaatc?ccactgagaa 6450
catacttgaa?gcgtagtacc?tgcccgaagt?atttgaaggc?tgtcctaggt 6500
attactaaac?tcaaagaaat?gttcacagac?acctctttat?tatacttgac 6550
tcgtgctcaa?caaaaattct?acatgaaaac?tataggcaat?gcagtcaagg 6600
gatattacag?taacggtaac?tcttaaaggc?aatcacatat?taatatgctt 6650
tccttctagc?caattgtatc?cttgttgacc?tgattatacc?atattagaaa 6700
aaa 6703
 
<210>4
<211>490
<212>PRT
<213〉newcastle disease virus Italien strain (Newcastle disease virus Italien strain)
 
<400>4
Met?Ser?Ser?Val?Phe?Asp?Glu?Tyr?Glu?Gln?Leu?Leu?Ala?Ala?Gln
1 5 10 15
Thr?Arg?Pro?Asn?Gly?Ala?His?Gly?Gly?Gly?Glu?Lys?Gly?Ser?Thr
20 25 30
Leu?Lys?Val?Glu?Val?Pro?Val?Phe?Thr?Leu?Asn?Ser?Asp?Asp?Pro
35 40 45
Glu?Asp?Arg?Trp?Asn?Phe?Ala?Val?Phe?Cys?Leu?Arg?Ile?Ala?Val
50 55 60
Ser?Glu?Asp?Ala?Asn?Lys?Pro?Leu?Arg?Gln?Gly?Ala?Leu?Ile?Ser
65 70 75
Leu?Leu?Cys?Ser?His?Ser?Gln?Val?Met?Arg?Asn?His?Val?Ala?Leu
80 85 90
Ala?Gly?Lys?Gln?Asn?Glu?Ala?Thr?Leu?Ala?Val?Leu?Glu?Ile?Asp
95 100 105
Gly?Phe?Thr?Asn?Ser?Val?Pro?Gln?Phe?Asn?Asn?Arg?Ser?Gly?Val
110 115 120
Ser?Glu?Glu?Arg?Ala?Gln?Arg?Phe?Leu?Met?Ile?Ala?Gly?Ser?Leu
125 130 135
Pro?Arg?Ala?Cys?Ser?Asn?Gly?Thr?Pro?Phe?Val?Thr?Ala?Gly?Val
140 145 150
Glu?Asp?Asp?Ala?Pro?Glu?Asp?Ile?Thr?Asp?Thr?Leu?Glu?Arg?Ile
155 160 165
Leu?Ser?Ile?Gln?Ala?Gln?Val?Trp?Val?Thr?Val?Ala?Lys?Ala?Met
170 175 180
Thr?Ala?Tyr?Glu?Thr?Ala?Asp?Glu?Ser?Glu?Thr?Arg?Arg?Ile?Asn
185 190 195
Lys?Tyr?Met?Gln?Gln?Gly?Arg?Val?Gln?Lys?Lys?Tyr?Ile?Leu?His
200 205 210
Pro?Val?Cys?Arg?Ser?Ala?Ile?Gln?Leu?Thr?Ile?Arg?His?Ser?Leu
215 220 225
Ala?Val?Arg?Ile?Phe?Leu?Val?Ser?Glu?Leu?Lys?Arg?Gly?Arg?Asn
230 235 240
Thr?Ala?Gly?Gly?Ser?Ser?Thr?Tyr?Tyr?Asn?Leu?Val?Gly?Asp?Val
245 250 255
Asp?Ser?Tyr?Ile?Arg?Asn?Thr?Gly?Leu?Thr?Ala?Phe?Phe?Leu?Thr
260 265 270
Leu?Lys?Tyr?Gly?Ile?Asn?Thr?Lys?Thr?Ser?Ala?Leu?Ala?Leu?Ser
275 280 285
Ser?Leu?Thr?Gly?Asp?Ile?Gln?Lys?Met?Lys?Gln?Leu?Met?Arg?Leu
290 295 300
Tyr?Arg?Ile?Lys?Gly?Glu?Asn?Ala?Pro?Tyr?Met?Thr?Leu?Leu?Gly
305 310 315
Asp?Ser?Asp?Gln?Met?Ser?Phe?Ala?Pro?Ala?Glu?Tyr?Ala?Gln?Leu
320 325 330
Tyr?Ser?Phe?Ala?Met?Gly?Met?Ala?Ser?Val?Leu?Asp?Lys?Gly?Thr
335 340 345
Gly?Lys?Tyr?Gln?Phe?Ala?Arg?Asp?Phe?Met?Ser?Thr?Ser?Phe?Trp
350 355 360
Arg?Leu?Gly?Val?Glu?Tyr?Ala?Gln?Ala?Gln?Gly?Ser?Ser?Ile?Asn
365 370 375
Glu?Asp?Met?Ala?Ala?Glu?Leu?Lys?Leu?Thr?Pro?Ala?Ala?Arg?Arg
380 385 390
Gly?Leu?Ala?Ala?Ala?Ala?Gln?Arg?Val?Ser?Glu?Glu?Thr?Gly?Ser
395 400 405
Met?Asp?Ile?Pro?Thr?Gln?Gln?Ala?Gly?Val?Leu?Thr?Gly?Leu?Ser
410 415 420
Asp?Gly?Gly?Pro?Arg?Ala?Pro?Gln?Gly?Gly?Ser?Asn?Arg?Pro?Gln
425 430 435
Gly?Gln?Pro?Asp?Ala?Gly?Asp?Gly?Glu?Thr?Gln?Phe?Leu?Asp?Leu
440 445 450
Met?Arg?Ala?Val?Ala?Asn?Ser?Met?Arg?Glu?Ala?Pro?Asn?Ser?Ala
455 460 465
Gln?Ser?Thr?Thr?Gln?Pro?Glu?Pro?Pro?Ser?Thr?Pro?Gly?Pro?Ser
470 475 480
Gln?Gly?Asn?Asp?Thr?Asp?Trp?Gly?Tyr?ter
485 490
 
<210>5
<211>396
<212>PRT
<213〉newcastle disease virus Italien strain (Newcastle disease virus Italien strain)
 
<400>5
Met?Ala?Thr?Phe?Thr?Asp?Ala?Glu?Ile?Asp?Asp?Ile?Phe?Glu?Thr
1 5 10 15
Ser?Gly?Thr?Val?Ile?Asp?Ser?Ile?Ile?Thr?Ala?Gln?Gly?Lys?Ser
20 25 30
Ala?Glu?Thr?Val?Gly?Arg?Ser?Ala?Ile?Pro?Gln?Gly?Lys?Thr?Lys
35 40 45
Ala?Leu?Ser?Ala?Ala?Trp?Glu?Lys?His?Gly?Ser?Ile?Gln?Pro?Pro
50 55 60
Ala?Ser?Gln?Asp?Thr?Leu?Asp?Gln?Gln?Asp?Arg?Ser?Asp?Lys?Gln
65 70 75
Pro?Ser?Thr?Pro?Glu?Gln?Ala?Thr?Pro?His?Asn?Ser?Pro?Pro?Ala
80 85 90
Thr?Ser?Thr?Asp?Gln?Pro?Pro?Thr?Gln?Ala?Ala?Gly?Glu?Ala?Gly
95 100 105
Asp?Thr?Gln?Leu?Lys?Thr?Gly?Ala?Ser?Asn?Ser?Leu?Leu?Ser?Met
110 115 120
Leu?Asp?Lys?Leu?Ser?Asn?Lys?Ser?Ser?Asn?Ala?Lys?Lys?Gly?Pro
125 130 135
Trp?Ala?Ser?Pro?Gln?Glu?Gly?His?His?Gln?Pro?Pro?Ala?Gln?Gln
140 145 150
Gln?Gly?Ser?Gln?Pro?Ser?Arg?Gly?Asn?Asn?Gln?Glu?Arg?Pro?Gln
155 160 165
Asn?Gln?Ala?Lys?Ala?Ala?Pro?Gly?Asp?Arg?Gly?Thr?Asp?Ala?Asn
170 175 180
Thr?Ala?Tyr?Pro?Gly?Gln?Trp?Lys?Glu?Ser?Gln?Leu?Ser?Ala?Gly
185 190 195
Val?Thr?Pro?His?Ala?Leu?Arg?Ser?Gly?Gln?Ser?Gln?Asp?Asn?Thr
200 205 210
Pro?Ala?Pro?Val?Asp?His?Val?Gln?Leu?Pro?Val?Asp?Phe?Val?Gln
215 220 225
Ala?Met?Met?Ser?Met?Met?Glu?Ala?Leu?Ser?Gln?Arg?Val?Ser?Lys
230 235 240
Val?Asp?Tyr?Gln?Leu?Asp?Leu?Val?Leu?Lys?Gln?Thr?Ser?Ser?Ile
245 250 255
Pro?Met?Met?Arg?Ser?Glu?Ile?Gln?Gln?Leu?LVs?Thr?Ser?Val?Ala
260 265 270
Val?Met?Glu?Ala?Asn?Leu?Gly?Met?Met?Lys?Ile?Leu?Asp?Pro?Gly
275 280 285
Cys?Ala?Asn?Val?Ser?Ser?Leu?Ser?Asp?Leu?Arg?Ala?Val?Ala?Arg
290 295 300
Ser?His?Pro?Val?Leu?Ile?Ser?Gly?Pro?Gly?Asp?Pro?Ser?Pro?Tyr
305 310 315
Val?Thr?Gln?Gly?Gly?Glu?Met?Thr?Leu?Asn?Lys?Leu?Ser?Gln?Pro
320 325 330
Val?Leu?His?Pro?Ser?Glu?Leu?Ile?Lys?Pro?Ala?Thr?Ala?Ser?Gly
335 340 345
Pro?Asp?Met?Gly?Val?Glu?Lys?Asp?Thr?Val?Arg?Ala?Leu?Ile?Thr
350 355 360
Ser?Arg?Pro?Met?His?Pro?Ser?Ser?Ser?Ala?Lys?Leu?Leu?Ser?Lys
365 370 375
Leu?Asp?Ala?Ala?Gly?Ser?Ile?Glu?Glu?Ile?Arg?Lys?Ile?Lys?Arg
380 385 390
Leu?Ala?Leu?Asn?Gly?ter
395?396
 
<210>6
<211>2205
<212>PRT
<213〉newcastle disease virus Italien strain (Newcastle disease virus Italien strain)
 
<400>6
Met?Ala?Ser?Ser?Gly?Pro?Glu?Arg?Ala?Glu?His?Gln?Ile?Ile?Leu
1 5 10 15
Pro?Glu?Ser?His?Leu?Ser?Ser?Pro?Leu?Val?Lys?His?Lys?Leu?Leu
20 25 30
Tyr?Tyr?Trp?Lys?Leu?Thr?Gly?Leu?Pro?Leu?Pro?Asp?Glu?Cys?Asp
35 40 45
Phe?Asp?His?Leu?Ile?Ile?Ser?Arg?Gln?Trp?Lys?Lys?Ile?Leu?Glu
50 55 60
Ser?Ala?Thr?Pro?Asp?Thr?Glu?Arg?Met?Ile?Lys?Leu?Gly?Arg?Ala
65 70 75
Val?His?Gln?Thr?Leu?Asn?His?Ser?Ser?Arg?Ile?Thr?Gly?Val?Leu
80 85 90
His?Pro?Arg?Cys?Leu?Glu?Glu?Leu?Ala?Ser?Ile?Glu?Val?Pro?Asp
95 100 105
Ser?Thr?Asn?Lys?Phe?Arg?Lys?Ile?Glu?Lys?Lys?Ile?Gln?Ile?His
110 115 120
Asn?Thr?Arg?Tyr?Gly?Glu?Leu?Phe?Thr?Arg?Leu?Cys?Thr?His?Val
125 130 135
Glu?Lys?Lys?Leu?Leu?Gly?Ser?Ser?Trp?Ser?Ser?Asn?Val?Pro?Arg
140 145 150
Ser?Glu?Glu?Phe?Asn?Ser?Ile?Arg?Thr?Asp?Pro?Ala?Phe?Trp?Phe
155 160 165
His?Ser?Lys?Trp?Ser?Arg?Ala?Lys?Phe?Ala?Trp?Leu?His?Ile?Lys
170 175 180
Gln?Val?Gln?Arg?His?Leu?Ile?Val?Ala?Ala?Arg?Thr?Arg?Ser?Ala
185 190 195
Val?Asn?Lys?Leu?Val?Thr?Leu?Thr?His?Lys?Ile?Gly?Gln?Val?Phe
200 205 210
Val?Thr?Pro?Glu?Leu?Val?Val?Val?Thr?His?Thr?Asp?Glu?Asn?Lys
215 220 225
Phe?Thr?Cys?Leu?Thr?Gln?Glu?Leu?Val?Leu?Met?Tyr?Ala?Asp?Met
230 235 240
Met?Glu?Gly?Arg?Asp?Met?Val?Asn?Ile?Ile?Ser?Ser?Thr?Ala?Ala
245 250 255
His?Leu?Lys?Ser?Leu?Ser?Glu?Lys?Ile?Asp?Asp?Ile?Leu?Arg?Leu
260 265 270
Val?Asp?Ala?Leu?Ala?Lys?Asp?Leu?Gly?Asn?Gln?Val?Tyr?Asp?Val
275 280 285
Val?Ala?Leu?Met?Glu?Gly?Phe?Ala?Tyr?Gly?Ala?Val?Gln?Leu?Leu
290 295 300
Glu?Pro?Ser?Gly?Thr?Phe?Ala?Gly?Asp?Phe?phe?Ala?Phe?Asn?Leu
305 310 315
Gln?Glu?Leu?Lys?Asp?Thr?Leu?Ile?Glu?Leu?Leu?Pro?Lys?Asp?Ile
320 325 330
Ala?Glu?Ser?Val?Thr?His?Ala?Ile?Ala?Thr?Val?Phe?Ser?Gly?Leu
335 340 345
Glu?Gln?Asn?Gln?Ala?Ala?Glu?Met?Leu?Cys?Leu?Leu?Arg?Leu?Trp
350 355 360
Gly?His?Pro?Leu?Leu?Glu?Ser?Arg?Val?Ala?Ala?Lys?Ala?Val?Arg
365 370 375
Ser?Gln?Met?Cys?Ala?Pro?Lys?Met?Val?Asp?Phe?Asp?Met?Ile?Leu
380 385 390
Gln?Val?Leu?Ser?Phe?Phe?Lys?Gly?Thr?Ile?Ile?Asn?Gly?Tyr?Arg
395 400 405
Lys?Lys?Asn?Ala?Gly?Val?Trp?Pro?Arg?Val?Lys?Met?Gly?Thr?Ile
410 415 420
Tyr?Gly?Lys?Val?Ile?Gly?Gln?Leu?His?Ala?Asp?Ser?Ala?Glu?Ile
425 430 435
Ser?His?Asp?Val?Met?Leu?Arg?Glu?Tyr?Lys?Ser?Leu?Ser?Ala?Leu
440 445 450
Glu?Phe?Glu?pro?Cys?Ile?Glu?Tyr?Asp?Pro?Val?Thr?Asn?Leu?Ser
455 460 465
Met?Phe?Leu?Lys?Asp?Lys?Ala?Ile?Ala?His?Pro?Lys?Asp?Asn?Trp
470 475 480
Leu?Ala?Ser?Phe?Arg?Arg?Asn?Leu?Leu?Ser?Glu?Asp?Gln?Lys?Lys
485 490 495
His?Val?Lys?Glu?Ala?Thr?Ser?Thr?Asn?Arg?Leu?Leu?Ile?Glu?Phe
500 505 510
Leu?Glu?Ser?Asn?Asp?Phe?Asp?Pro?Tyr?Lys?Glu?Met?Glu?Tyr?Leu
515 520 525
Thr?Thr?Leu?Glu?Tyr?Leu?Arg?Asp?Asp?Asn?Val?Ala?Val?Ser?Tyr
530 535 540
Ser?Leu?Lys?Glu?Lys?Glu?Val?Lys?Val?Asn?Gly?Arg?Ile?Phe?Ala
545 550 555
Lys?Leu?Thr?Lys?Lys?Leu?Arg?Asn?Cys?Gln?Val?Met?Ala?Glu?Gly
560 565 570
Ile?Leu?Ala?Asp?Gln?Ile?Ala?Pro?Phe?Phe?Gln?Gly?Asn?Gly?Val
575 580 585
Ile?Gln?Asp?Ser?Ile?Ser?Leu?Thr?Lys?Ser?Met?Leu?Ala?Met?Ser
590 595 600
Gln?Leu?Ser?Phe?Asn?Ser?Asn?Lys?Lys?Arg?Ile?Thr?Asp?Cys?Lys
605 610 615
Glu?Arg?Val?Ser?Ser?Thr?Arg?Asn?His?Asp?Pro?Lys?Ser?Lys?Asn
620 625 630
Arg?Arg?Arg?Val?Ala?Thr?Phe?Ile?Thr?Thr?Asp?Leu?Gln?Lys?Tyr
635 640 645
Cys?Leu?Asn?Trp?Arg?Tyr?Gln?Thr?Val?Lys?Leu?Phe?Ala?His?Ala
650 655 660
Ile?Asn?Gln?Leu?Met?Gly?Leu?Pro?His?Phe?Phe?Glu?Trp?Ile?His
665 670 675
Leu?Arg?Leu?Met?Asp?Thr?Thr?Met?Phe?Val?Gly?Asp?Pro?Tyr?Asn
680 685 690
Pro?Pro?Ser?Asp?Pro?Thr?Asp?Cys?Asp?Leu?Ser?Arg?Val?Pro?Asn
695 700 705
Asp?Asp?Ile?Tyr?Ile?Val?Ser?Ala?Arg?Gly?Gly?Ile?Glu?Gly?Leu
710 715 720
Cys?Gln?Lys?Leu?Trp?Thr?Met?Ile?Ser?Ile?Ala?Ala?Ile?Gln?Leu
725 730 735
Ala?Ala?Ala?Arg?Ser?His?Cys?Arg?Val?Ala?Cys?Met?Val?Gln?Gly
740 745 750
Asp?Asn?Gln?Val?Ile?Ala?Val?Thr?Arg?Glu?Val?Arg?Ser?Asp?Asp
755 760 765
Ser?Pro?Glu?Met?Val?Leu?Thr?Gln?Leu?His?Gln?Ala?Ser?Asp?Asn
770 775 780
Phe?Phe?Lys?Glu?Leu?Ile?His?Val?Asn?His?Leu?Ile?Gly?His?Asn
785 790 795
Leu?Lys?Asp?Arg?Glu?Thr?Ile?Arg?Ser?Asp?Thr?Phe?Phe?Ile?Tyr
800 805 810
Ser?Lys?Arg?Ile?Phe?Lys?Asp?Gly?Ala?Ile?Leu?Ser?Gln?Val?Leu
815 820 825
Lys?Asn?Ser?Ser?Lys?Leu?Val?Leu?Ile?Ser?Gly?Asp?Leu?Ser?Glu
830 835 840
Asn?Thr?Val?Met?Ser?Cys?Ala?Asn?Ile?Ala?Ser?Thr?Ile?Ala?Arg
845 850 855
Leu?Cys?Glu?Asn?Gly?Leu?Pro?Lys?Asp?Phe?Cys?Tyr?Tyr?Leu?Asn
860 865 870
Tyr?Leu?Met?Ser?Cys?Val?Gln?Thr?Tyr?Phe?Asp?Ser?Glu?Phe?Ser
875 880 885
Ile?Thr?Asn?Asn?Ser?Gln?Pro?Asp?Ser?Asn?Gln?Ser?Trp?Ile?Glu
890 895 900
Asp?Ile?Ser?Phe?Val?His?Ser?Tyr?Val?Leu?Thr?Pro?Ala?Gln?Leu
905 910 915
Gly?Gly?Leu?Ser?Asn?Leu?Gln?Tyr?Ser?Arg?Leu?Tyr?Thr?Arg?Asn
920 925 930
Ile?Gly?Asp?Pro?Gly?Thr?Thr?Ala?Phe?Ala?Glu?Val?Lys?Arg?Leu
935 940 945
Glu?Ala?Val?Gly?Leu?Leu?Ser?Pro?Ser?Ile?Met?Thr?Asn?Ile?Leu
950 955 960
Thr?Arg?Pro?Pro?Gly?Asn?Gly?Asp?Trp?Ala?Ser?Leu?Cys?Asn?Asp
965 970 975
Pro?Tyr?Ser?Phe?Asn?Phe?Glu?Thr?Val?Ala?Ser?Pro?Asn?Ile?Val
980 985 990
Leu?Lys?Lys?His?Thr?Gln?Lys?Val?Leu?Phe?Glu?Thr?Cys?Ser?Asn
995 1000 1005
Pro?Leu?Leu?Ser?Gly?Val?His?Thr?Glu?Asp?Asn?Glu?Ala?Glu?Glu
1010 1015 1020
Lys?Ala?Leu?Ala?Glu?Phe?Leu?Leu?Asn?Gln?Glu?Val?Ile?His?Pro
1025 1030 1035
Arg?Val?Ala?His?Ala?Ile?Met?Glu?Ala?Ser?Ser?Val?Gly?Arg?Arg
1040 1045 1050
Lys?Gln?Ile?Gln?Gly?Leu?Val?Asp?Thr?Thr?Asn?Thr?Val?Ile?Lys
1055 1060 1065
Ile?Ala?Leu?Thr?Arg?Arg?Pro?Leu?Gly?Ile?Lys?Arg?Leu?Met?Arg
1070 1075 1080
Ile?Val?Asn?Tyr?Ser?Ser?Met?His?Ala?Met?Leu?Phe?Arg?Asp?Asp
1085 1090 1095
Val?Phe?Ser?Ser?Asn?Arg?Ser?Asn?His?Pro?Leu?Val?Ser?Ser?Asn
1100 1105 1110
Met?Cys?Ser?Leu?Thr?Leu?Ala?Asp?Tyr?Ala?Arg?Asn?Arg?Ser?Trp
1115 1120 1125
Ser?Pro?Leu?Thr?Gly?Gly?Arg?Lys?Ile?Leu?Gly?Val?Ser?Asn?Pro
1130 1135 1140
Asp?Thr?Ile?Glu?Leu?Val?Glu?Gly?Glu?Ile?Leu?Ser?Val?Ser?Gly
1145 1150 1155
Gly?Cys?Thr?Lys?Cys?Asp?Ser?Gly?Asp?Glu?Gln?Phe?Thr?Trp?Phe
1160 1165 1170
His?Leu?Pro?Ser?Asn?Ile?Glu?Leu?Thr?Asp?Asp?Thr?Ser?Lys?Asn
1175 1180 1185
Pro?Pro?Met?Arg?Val?Pro?Tyr?Leu?Gly?Ser?Lys?Thr?Gln?Glu?Arg
1190 1195 1200
Arg?Ala?Ala?Ser?Leu?Ala?Lys?Ile?Ala?His?Met?Ser?Pro?His?Val
1205 1210 1215
Lys?Ala?Ala?Leu?Arg?Ala?Ser?Ser?Val?Leu?Ile?Trp?Ala?Tyr?Gly
1220 1225 1230
Asp?Asn?Glu?Val?Asn?Trp?Thr?Ala?Ala?Leu?Lys?Ile?Ala?Lys?Ser
1235 1240 1245
Arg?Cys?Asn?Ile?Ser?Ser?Glu?Tyr?Leu?Arg?Leu?Leu?Ser?pro?Leu
1250 1255 1260
Pro?Thr?Ala?Gly?Asn?Leu?Gln?His?Arg?Leu?Asp?Asp?Gly?Ile?Thr
1265 1270 1275
Gln?Met?Thr?Phe?Thr?Pro?Ala?Ser?Leu?Tyr?Arg?Val?Ser?Pro?Tyr
1280 1285 1290
Ile?His?Ile?Ser?Asn?Asp?Ser?Gln?Arg?Leu?Phe?Thr?Glu?Glu?Gly
1295 1300 1305
Val?Lys?Glu?Gly?Asn?Val?Val?Tyr?Gln?Gln?Ile?Met?Leu?Leu?Gly
1310 1315 1320
Leu?Ser?Leu?Ile?Glu?Ser?Leu?Phe?Pro?Met?Thr?Thr?Thr?Lys?Thr
1325 1330 1335
Tyr?Asp?Glu?Ile?Thr?Leu?His?Leu?His?Ser?Lys?Phe?Ser?Cys?Cys
1340 1345 1350
Ile?Arg?Glu?Ala?Pro?Val?Ala?Val?Pro?Phe?Glu?Leu?Leu?Gly?Leu
1355 1360 1365
Ala?Pro?Glu?Leu?Arg?Ala?Val?Thr?Ser?Asn?Lys?Phe?Met?Tyr?Asp
1370 1375 1380
Pro?Ser?Pro?Val?Ser?Glu?Gly?Asp?Phe?Ala?Arg?Leu?Asp?Leu?Ala
1385 1390 1395
Ile?Phe?Lys?Ser?Tyr?Glu?Leu?Asn?Leu?Glu?Ser?Tyr?Pro?Thr?Ile
1400 1405 1410
Glu?Leu?Met?Asn?Ile?Leu?Ser?Ile?Ser?Ser?Gly?Lys?Leu?Ile?Gly
1415 1420 1425
Gln?Ser?Val?Val?Ser?Tyr?Asp?Glu?Asp?Thr?Ser?Ile?Lys?Asn?Asp
1430 1435 1440
Ala?Ile?Ile?Val?Tyr?Asp?Asn?Thr?Arg?Asn?Trp?Ile?Ser?Glu?Ala
1445 1450 1455
Gln?Asn?Ser?Asp?Val?Val?Arg?Leu?Phe?Glu?Tyr?Ala?Ala?Leu?Glu
1460 1465 1470
Val?Leu?Leu?Asp?Cys?Ser?Tyr?Gln?Leu?Tyr?Tyr?Leu?Arg?Val?Arg
1475 1480 1485
Gly?Leu?Asn?Asn?Ile?Val?Leu?Tyr?Met?Ser?Asp?Leu?Tyr?Lys?Asn
1490 1495 1500
Met?Pro?Gly?Ile?Leu?Leu?Ser?Asn?Ile?Ala?Ala?Thr?Ile?Ser?His
1505 1510 1515
Pro?Ile?Ile?His?Ser?Arg?Leu?Asn?Ala?Val?Gly?Leu?Val?Asn?His
1520 1525 1530
Asp?Gly?Ser?His?Gln?Leu?Ala?Asp?Thr?Asp?Phe?Ile?Glu?Met?Ser
1535 1540 1545
Ala?Lys?Leu?Leu?Val?Ser?Cys?Thr?Arg?Arg?Val?Val?Ser?Gly?Leu
1550 1555 1560
Tyr?Ala?Gly?Asn?Arg?Tyr?Asp?Leu?Leu?Phe?Pro?Ser?Val?Leu?Asp
1565 1570 1575
Asp?Asn?Leu?Ser?Glu?Lys?Met?Leu?Gln?Leu?Ile?Ser?Arg?Leu?Cys
1580 1585 1590
Cys?Lau?Tyr?Thr?Val?Leu?Phe?Ala?Thr?Thr?Arg?Glu?Ile?Pro?Lys
1595 1600 1605
Ile?Arg?Gly?Leu?Ser?Ala?Glu?Glu?Lys?Cys?Ser?Val?Leu?Thr?Glu
1610 1615 1620
Tyr?Leu?Leu?Ser?Asp?Ala?Val?Lys?Pro?Leu?Leu?Arg?Ser?Glu?Gln
1625 1630 1635
Val?Ser?Ser?Ile?Met?Ser?Pro?Asn?Ile?Ile?Thr?Phe?Pro?Ala?Asn
1640 1655 1650
Leu?Tyr?Tyr?Met?Ser?Arg?Lys?Ser?Leu?Asn?Leu?Val?Arg?Glu?Arg
1655 1660 1665
Glu?Asp?Arg?Asp?Thr?Ile?Leu?Ala?Leu?Leu?Phe?Pro?Gln?Glu?Pro
1670 1675 1680
Leu?Leu?Glu?Phe?Pro?Ser?Val?Gln?Asp?Ile?Gly?Ala?Arg?Val?Lys
1685 1690 1695
Asp?Pro?Phe?Thr?Arg?Gln?Pro?Ala?Ala?Phe?Leu?Gln?Glu?Leu?Asp
1700 1705 1710
Leu?Ser?Ala?Pro?Ala?Arg?Tyr?Asp?Ala?Phe?Thr?Leu?Ser?Gln?Val
1715 1720 1725
His?Ser?Glu?His?Thr?Leu?Pro?Asn?Pro?Glu?Glu?Asp?Tyr?Leu?Val
1730 1735 1740
Arg?Tyr?Leu?Phe?Arg?Gly?Ile?Gly?Thr?Ala?Ser?Ser?Ser?Trp?Tyr
1745 1750 1755
Lys?Ala?Ser?His?Leu?Leu?Ser?Val?Pro?Glu?Val?Arg?Cys?Ala?Arg
1760 1765 1770
His?Gly?Asn?Ser?Leu?Tyr?Leu?Ala?Glu?Gly?Ser?Gly?Ala?Ile?Met
1775 1780 1785
Ser?Leu?Leu?Glu?Leu?His?Val?Pro?His?Glu?Thr?Ile?Tyr?Tyr?Asn
1790 1795 1800
Thr?Leu?Phe?Ser?Asn?Glu?Met?Asn?Pro?Pro?Gln?Arg?His?Phe?Gly
1805 1810 1815
Pro?Thr?Pro?Thr?Gln?Phe?Leu?Asn?Ser?Val?Val?Tyr?Arg?Asn?Leu
1820 1825 1830
Gln?Ala?Glu?Val?Pro?Cys?Lys?Asp?Gly?Phe?Val?Gln?Glu?Phe?His
1835 1840 1845
Pro?Leu?Trp?Arg?Glu?Asn?Thr?Glu?Glu?Ser?Asp?Leu?Thr?Ser?Asp
1850 1855 1860
Lys?Ala?Val?Gly?Tyr?Ile?Thr?Ser?Ala?Val?Pro?Tyr?Arg?Ser?Val
1865 1870 1875
Ser?Leu?Leu?His?Cys?Asp?Ile?Glu?Ile?Pro?Pro?Gly?Ser?Asn?Gln
1880 1885 1890
Ser?Leu?Leu?Asp?Gln?Leu?Ala?Thr?Asn?Leu?Ser?Leu?Ile?Ala?Met
1895 1900 1905
His?Ser?Val?Arg?Glu?Gly?Gly?Val?Val?Ile?Ile?Lys?Val?Leu?Tyr
1910 1915 1920
Ala?Met?Gly?Tyr?Tyr?Phe?His?Leu?Leu?Met?Asn?Leu?Phe?Ala?Pro
1925 1930 1935
Cys?Ser?Thr?Lys?Gly?Tyr?Ile?Leu?Ser?Asn?Gly?Tyr?Ala?Cys?Arg
1940 1945 1950
Gly?Asp?Met?Glu?Cys?Tyr?Leu?Ile?Phe?Val?Met?Gly?Tyr?Leu?Gly
1955 1960 1965
Gly?Pro?Thr?Phe?Val?His?Glu?Val?Val?Arg?Met?Ala?Lys?Thr?Leu
1970 1975 1980
Val?Arg?Arg?His?Gly?Thr?Leu?Leu?Ser?Lys?Ser?Asp?Glu?Ile?Thr
1985 1990 1995
Leu?Thr?Arg?Leu?Phe?Thr?Ser?Gln?Gln?His?Arg?Val?Thr?Asp?Ile
2000 2005 2010
Leu?Ser?Ser?Pro?Leu?Pro?Arg?Leu?Met?Lys?phe?Leu?Arg?Glu?Asn
2015 2020 2025
Ile?Asp?Ala?Ala?Leu?Ile?Glu?Ala?Gly?Gly?Gln?Pro?Val?Arg?Pro
2030 2035 2040
Phe?Cys?Ala?Glu?Ser?Leu?Val?Ser?Thr?Leu?Lys?Asp?Met?Thr?Gln
2045 2050 2055
Met?Thr?Gln?Ile?Ile?Ala?Ser?His?Ile?Asp?Thr?Val?Ile?Arg?Ser
2060 2065 2070
Val?Ile?Tyr?Met?Glu?Ala?Glu?Gly?Asp?Leu?Ala?Asp?Thr?Val?Phe
2075 2080 2085
Leu?Phe?Thr?Pro?Tyr?Asn?Leu?Ser?Thr?Asp?Gly?Lys?Lys?Arg?Thr
2090 2095 2100
Ser?Leu?Lys?Gln?Cys?Thr?Arg?Gln?Ile?Leu?Glu?Val?Thr?Ile?Leu
2105 2110 2115
Gly?Leu?Arg?Ala?Lys?Asp?Leu?Asn?Lys?Val?Gly?Asp?Val?Ile?Gly
2120 2125 2130
Leu?Val?Leu?Arg?Gly?Met?Ile?Ser?Leu?Glu?Asp?Leu?Ile?Pro?Leu
2135 2140 2145
Arg?Thr?Tyr?Leu?Lys?Arg?Ser?Thr?Cys?Pro?Lys?Tyr?Leu?Lys?Ala
2150 2155 2160
Val?Leu?Gly?Ile?Thr?Lys?Leu?Lys?Glu?Met?Phe?Thr?Asp?Thr?Ser
2165 2170 2175
Leu?Leu?Tyr?Leu?Thr?Arg?Ala?Gln?Gln?Lys?Phe?Tyr?Met?Lys?Thr
2180 2185 2190
Ile?Gly?Asn?Ala?Val?Lys?Gly?Tyr?Tyr?Ser?Asn?Gly?Asn?Ser?ter
2195 2200 2205
 
<210>7
<211>121
<212>DNA
<213〉newcastle disease virus Italien strain (Newcastle disease virus)
 
<220>
<221>3′UTP
<222>(1)..(121)
<223〉newcastle disease virus Italien strain genome 3 ' non-coding region
 
<400>7
accaaacaga?gattctgtga?ggtacgataa?aaggcgaagg?agcaatcgaa 50
gtcgtacggg?tagaaggtgt?gaatctcgag?tgcgaggccg?aagctcaaac 100
tcgagagagc?cttctgctga?c 121
 
<210>8
<211>191
<212>DNA
<213〉newcastle disease virus Italien strain (Newcastle disease virus)
 
<220>
<221>5′UTP
<222>(1)..(191)
<223〉newcastle disease virus Italien strain genome 5 ' non-coding region
 
<400>8
aggcaatcac?atattaatat?gctttccttc?tagccaattg?tatccttgtt 50
gacctgatta?taccatatta?gaaaaaagtt?gaatcccgac?cctttaagac 100
tcgtattcgg?attcaaataa?ttatcttaaa?acagaagtgc?gcatagttgt 150
tcttgattat?aatcctgtca?ttcaccaaat?ctttgtttgg?t 191

Claims (8)

1. newcastle disease virus Italien strain auxiliary expression pUC pUC, comprise NP gene based on the newcastle disease virus Italien strain of pcDNA3.1 (+) plasmid construction, the eukaryon expression plasmid pcDNA-NP of P gene and L gene, pcDNA-P and pcDNA-L, wherein NP gene expression plasmid pcDNA-NP comprises the sequence of SEQ No 1, its expression product comprises the aminoacid sequence of SEQ No 4, P gene expression plasmid pcDNA-P comprises the sequence of SEQ No 2, its expression product comprises the aminoacid sequence of SEQ No 5, L gene expression plasmid pcDNA-L comprises the sequence of SEQ No 3, its expression product comprises the aminoacid sequence of SEQ No 6, and above-mentioned plasmid is expressed newcastle disease virus Italien strain NP albumen respectively in eukaryotic cell, P albumen and L albumen.
2. newcastle disease virus Italien strain auxiliary expression pUC pUC, the NP gene that comprises newcastle disease virus Italien strain, P gene and L expression of gene plasmid T7-NP, T7-P and T7-L, only there is the t7 rna polymerase promotor in described plasmid, and insert the NP of internal ribosome entry site (IRES) sequence and newcastle disease virus Italien strain successively in the downstream, P and L albumen coded sequence, wherein NP gene expression plasmid T7-NP comprises the sequence of SEQ No 1, its expression product comprises the aminoacid sequence of SEQ No 4, P gene expression plasmid T7-P comprises the sequence of SEQ No2, its expression product comprises the aminoacid sequence of SEQ No 5, L gene expression plasmid T7-L comprises the sequence of SEQ No3, its expression product comprises the aminoacid sequence of SEQ No 6, and above-mentioned plasmid is expressed newcastle disease virus Italien strain NP albumen respectively in the eukaryotic cell that contains the T7 RNA polymerase, P albumen and L albumen.
3. detect the micro genome of newcastle disease virus Italien strain auxiliary expression pUC pUC as claimed in claim 1, it is characterized in that: between t7 rna polymerase promoter sequence and hepatitis D virus autocatalysis ribozyme (HDVribozyme) sequence, oppositely insert newcastle disease virus Italien strain genome 3 ' non-coding region cDNA sequence, label protein encoding sequence and newcastle disease virus Italien strain genome 5 ' non-coding region cDNA sequence, wherein Avian pneumo-encephalitis virus Italen pnca gene group 3 ' non-coding region cDNA sequence comprises the sequence of SEQ No 7, newcastle disease virus Italien strain genome 5 ' non-coding region cDNA sequence comprises the sequence of SEQ No 8, described micro genome is transcribed by the t7 rna polymerase guiding gene, there is newcastle disease virus Italien strain NP albumen at the same time in transcription product, when P albumen and L albumen, in eukaryotic cell, express its label protein that carries.
4. detect the micro genome of newcastle disease virus Italien strain auxiliary expression pUC pUC as claimed in claim 2, it is characterized in that: between t7 rna polymerase promoter sequence and hepatitis D virus autocatalysis ribozyme (HDVribozyme) sequence, oppositely insert newcastle disease virus Italien strain genome 3 ' non-coding region cDNA sequence, label protein encoding sequence and newcastle disease virus Italien strain genome 5 ' non-coding region cDNA sequence, wherein newcastle disease virus Italien strain genome 3 ' non-coding region cDNA sequence comprises the sequence of SEQ No 7, newcastle disease virus Italien strain genome 5 ' non-coding region cDNA sequence comprises the sequence of SEQ No 8, described micro genome is transcribed by T7 RNA polymerase guiding gene, there is newcastle disease virus Italien strain NP albumen at the same time in transcription product, when P albumen and L albumen, in eukaryotic cell, express its label protein that carries.
5. newcastle disease virus Italien strain auxiliary expression pUC pUC as claimed in claim 1 is as external preparation recombinant virus or as the application for preparing viral micro genome.
6. newcastle disease virus Italien strain auxiliary expression pUC pUC as claimed in claim 2 is as external preparation recombinant virus or as the application for preparing viral micro genome.
7. the micro genome of detection newcastle disease virus Italien strain auxiliary expression pUC pUC as claimed in claim 3 is as external preparation recombinant virus or as the application in preparation newcastle disease virus Italien strain NP albumen, P albumen and L albumen or the Function Identification.
8. the micro genome of detection newcastle disease virus Italien strain auxiliary expression pUC pUC as claimed in claim 4 is as external preparation recombinant virus or as the application in preparation newcastle disease virus Italien strain NP albumen, P albumen and L albumen or the Function Identification.
CN201010179881XA 2010-09-22 2010-09-22 Newcastle disease virus Italien strain auxiliary expression plasmid systems, micro genome for detecting system and application thereof Pending CN101928727A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010179881XA CN101928727A (en) 2010-09-22 2010-09-22 Newcastle disease virus Italien strain auxiliary expression plasmid systems, micro genome for detecting system and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010179881XA CN101928727A (en) 2010-09-22 2010-09-22 Newcastle disease virus Italien strain auxiliary expression plasmid systems, micro genome for detecting system and application thereof

Publications (1)

Publication Number Publication Date
CN101928727A true CN101928727A (en) 2010-12-29

Family

ID=43368156

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010179881XA Pending CN101928727A (en) 2010-09-22 2010-09-22 Newcastle disease virus Italien strain auxiliary expression plasmid systems, micro genome for detecting system and application thereof

Country Status (1)

Country Link
CN (1) CN101928727A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103343141A (en) * 2013-06-20 2013-10-09 陈志南 Restructured newcastle disease virus/genome plasmid for expressing humanized chimeric antibody cHAb18 and application thereof in anti-tumor treatment
CN104610449A (en) * 2015-01-15 2015-05-13 上海交通大学 Transmembrane intracellular antibody for chicken-derived anti-NDV (Newcastle disease virus) P protein, preparation method and application of transmembrane intracellular antibody
CN114908095A (en) * 2022-06-09 2022-08-16 南开大学 Method for targeted inhibition of target RNA based on ribozyme and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101205544A (en) * 2007-08-07 2008-06-25 中国人民解放军第四军医大学 Tumor targeting recombinant newcastle disease viruses and construction method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101205544A (en) * 2007-08-07 2008-06-25 中国人民解放军第四军医大学 Tumor targeting recombinant newcastle disease viruses and construction method thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
《中国家禽》 20061231 张艳梅 等 鹅源新城疫病毒ZJ1株拯救体系相关因素的探索 26-30 3-8 第28卷, 第13期 2 *
《微生物学报》 20050228 张艳梅 等 鹅源新城疫病毒ZJ1株微型基因组的构建及其初步应用 72-76 3-8 第45卷, 第1期 2 *
《第四军医大学硕士学位论文》 20071231 张华 新城疫病毒HN和F蛋白的表达及对肝癌细胞多核融合作用的研究 全文 1-8 , 2 *
《西北农林科技大学学报(自然科学版)》 20100630 韩青松 等 鸽源新城疫病毒陕西分离株P基因的克隆及序列分析 7-12 1-8 第38卷, 第6 期 2 *
《解放军医学杂志》 20070228 张华 等 天然溶瘤新城疫病毒Italien 株HN基因真核表达载体的构建和表达 100-103 1-8 第32卷, 第2期 2 *
袁志刚 等: "原核表达系统T7 RNA聚合酶/启动子在真核细胞中表达目的基因的实验研究", 《生物工程学报》, vol. 21, no. 2, 31 March 2005 (2005-03-31), pages 182 - 186 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103343141A (en) * 2013-06-20 2013-10-09 陈志南 Restructured newcastle disease virus/genome plasmid for expressing humanized chimeric antibody cHAb18 and application thereof in anti-tumor treatment
CN104610449A (en) * 2015-01-15 2015-05-13 上海交通大学 Transmembrane intracellular antibody for chicken-derived anti-NDV (Newcastle disease virus) P protein, preparation method and application of transmembrane intracellular antibody
CN104610449B (en) * 2015-01-15 2017-12-15 上海交通大学 The transmembrane intracellular antibody of one breeder source property anti-newcastle disease virus P albumen, preparation method and applications
CN114908095A (en) * 2022-06-09 2022-08-16 南开大学 Method for targeted inhibition of target RNA based on ribozyme and application thereof

Similar Documents

Publication Publication Date Title
Peeters et al. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence
Liu et al. A polycistronic mRNA specified by the coronavirus infectious bronchitis virus
CN113736800B (en) Pigeon-derived Newcastle disease virus recombinant vaccine strain and construction method and application thereof
CN108004270B (en) Method for detecting activity of duck IFN-beta promoter by using dual-luciferase reporter gene
CN102741405A (en) System for increasing gene expression, and vector supporting said system
KR20010053000A (en) Newcastle disease virus infectious clones, vaccines and diagnostic assays
AU2007224430A1 (en) Recombinant Newcastle disease virus expressing H5 hemagglutinin of avian influenza virus
CN110279854A (en) A kind of Micropterus salmoides virus DNA vaccine and the preparation method and application thereof
CN109321534A (en) A kind of recombination VIII type newcastle disease virus low virulent strain
CN104962581A (en) Recombined new castle disease virus vaccine strain for expressing African swine fever virus p72 proteins
CN106755089B (en) Cell line for expressing goat lymphocyte activating molecules and construction method and application thereof
KR102277763B1 (en) Avian cells for improved virus production
EP3844268A1 (en) Novel recombinant newcastle disease virus
CN101928727A (en) Newcastle disease virus Italien strain auxiliary expression plasmid systems, micro genome for detecting system and application thereof
Min et al. Generation of antiviral transgenic chicken using spermatogonial stem cell transfected in vivo
Ling et al. Sequence and in vitro expression of the phosphoprotein gene of avian pneumovirus
CN103451198B (en) The full-length infectious CDNA of oncolytic type newcastle disease virus D 90 strain and construction process thereof and application
Fujii et al. Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of a pathogenic field isolate from cDNA
CN113637695B (en) Novel coronavirus mRNA vaccine for targeted stimulation of humoral immunity and cellular immunity
BRPI0709613A2 (en) method for producing a recombinant mononegaviral virus vector, recombinant mononegaviral virus vector, and vaccine against a microbial pathogen
Morimoto et al. A unique transcription mode of rabies virus high egg passage‐Flury strain detected in infected baby hamster kidney‐21 cells
KR101636683B1 (en) New castle disease virus bp acndm with improved thermostable property
Yunus et al. Sequence analysis of a functional polymerase (L) gene of bovine respiratory syncytial virus: determination of minimal trans-acting requirements for RNA replication
CN105601726B (en) Application of the Oct4 in regulation IL-31 gene expression
CN109868288A (en) Cas9 transcription templates DNA and Plasmid DNA and in-vitro transcription method for drosophila CRISPR transgenosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20101229